Head of Portfolio Strategy and Business Development

As a core member of CPS&CSI you will oversee the comprehensive management of the Roche China portfolio through prioritization acceleration of Roche pipeline and bringing new pipeline launch excellence competitor intelligence business development and late stage lifecycle management. The expected key outcomes are:

• Define China short/mid/long-term strategic goals and outcomes to deliver the overarching vision

• Develop the overall portfolio prioritization strategy for short mid and long term

• Initiate and prioritize corporate level strategic engagements and follow through to track outcome

• Establish the framework and mechanism of an integrated pipeline planning process and launch roadmap

• Responsible for BD transactions for all commercial opportunities in China for China.

• Develop BD strategies to enhance our internal LifeCycle management activities execute on business development needs for Roche including implementing new alternative commercial models

• Manage key strategic alliances with importance for China

• Provide the China perspective to Pharma Partnering for all deals

• Be the focal point for Established products lifecycle Team to align strategies and implement as relevant for China

• Strengthen the collaboration with the global relevant counterparts to ensure Chinas early and strong presence

Principle Roles & Responsibilities / Accountabilities 主要职责/责任
(Major functions of the position) 职位的首要职能

• Take a lead to support and integrate the inputs from various partners to define China short/mid/long-term strategic goals and outcomes to deliver the overarching vision with solid data and sound business rationale.

• Develop the overall portfolio prioritization strategy for short mid and long term playing a lead role in shaping the commercial development of Pharma Chinas future brands and significantly influencing management team and key stakeholders.

• Acts as a trusted advisor to the businesss leadership and relevant stakeholders initiates and prioritizes corporate level strategic engagements and follows through to track outcome.

• Establish the framework and mechanism of an integrated pipeline planning process and launch roadmap and develop strategy direction and priorities to evolve the current Roche China portfolio provide directions for internal as well as external assets sourcing focus.

• Identifying and implementing high-priority pre-launch and launch initiatives meet or beat launch timelines quality standards and other performance metrics

• Enable a high degree of cross-functional communication inputs gathering and alignment developing sharing and driving best practices scalable and sustainable processes standards and tools to support excellence performing.

• Responsible for BD transactions for all late state commercial opportunities

Qualification and Experience 能力与经验

• Bachelors degree or above MBA or an advanced degree in Business Administration Strategy or Finance is strongly preferred.

• More than 10 years of progressive experience within the pharmaceutical industry specifically in portfolio strategy corporate development or pipeline management.

• Proven track record of evaluating and executing late-stage commercial BD transactions asset sourcing and alliance management within China.

• Proven capability to collaborate effectively with global counterparts represent the China perspective and advise executive leadership

• Exceptional communication skills to lead cross-functional teams align strategies across matrices and manage key strategic alliances.

• Demonstrated ability to empower team members simplify complex priorities and drive excellence in alignment with leadership expectations.

• Take genuine interest in people

• Listen carefully tell the truth and explain the why

• Empower and trust people to make decisions

• Discover and develop the potential in people

• Strive for excellence and extraordinary result

• Set priorities and simplify work

• Congratulate people for a job well done